Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3004347	s-hdvab	— (—)	139	143	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

16.50

60.71

1.0

1.1

—

Viral hepatitis, including avohilmo

91.75

57.04

1.0

—

Viral hepatitis

87.41

54.05

1.1

1.0

—

Other viral hepatitis, including avohilmo

98.64

52.99

1.1

1.0

—

Other viral hepatitis

114.32

51.97

1.1

1.0

—

Chronic viral hepatitis

108.53

48.97

1.1

1.0

—

Certain infectious and parasitic diseases

9.62

27.94

1.0

—

GASTRO-related operations

8.84

20.56

1.0

1.1

—

Any gastric operation

8.84

20.56

1.0

1.1

—

Acute hepatitis B, including avohilmo

+∞

14.79

1.0

0.0

—

Certain infectious and parasitic diseases, including avohilmo

9.64

14.61

1.0

—

Septicaemia

6.44

14.26

1.0

1.1

—

Explicit Sepsis, including avohilmo

5.75

13.84

1.0

—

Other diseases of liver

17.54

13.80

1.0

1.1

—

Acute hepatitis B

+∞

13.73

1.0

0.0

—

Other septicaemia, including avohilmo

6.66

13.64

1.0

—

Other bacterial diseases, including avohilmo

3.68

12.81

1.0

1.1

—

Explicit Sepsis

5.47

12.17

1.0

1.1

—

General symptoms and signs

3.51

11.35

1.0

—

Other bacterial diseases

3.57

11.23

1.0

—

Substance abuse, excluding more controls

4.18

10.92

1.0

1.1

—

Bacterial infection, other or unspecified

4.49

9.97

1.0

—

Bacterial infection, other or unspecified, including avohilmo

4.35

9.89

1.0

—

Mental and behavioural disorders due to psychoactive substance use

3.69

9.85

1.0

1.1

—

Substance abuse

3.62

9.34

1.0

—

Fever of other and unknown origin

4.16

9.20

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

15.62

9.02

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

10.69

8.77

1.0

—

Implicit bacterial Sepsis, including avohilmo

4.89

8.77

1.0

—

Other septicaemia

6.60

8.57

1.0

—

3.50

8.48

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

20.18

8.48

1.0

—

Fibrosis and cirrhosis of liver

20.07

8.46

1.0

—

Bacterial Sepsis

4.72

8.42

1.0

—

Depression

2.97

8.40

1.0

—

Mood [affective] disorders

2.89

8.32

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.85

8.31

1.0

—

Mood disorders

2.89

8.30

1.0

—

Other inflammatory liver diseases

17.21

8.07

1.0

—

Mental and behavioural disorders due to opioids

22.13

8.02

1.0

—

Intestinal infectious diseases

2.91

7.97

1.0

—

Symptoms and signs involving the digestive system and abdomen

3.12

7.86

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3.10

7.70

1.0

—

Alcohol use disorder, Swedish definition

3.48

7.63

1.0

—

Infections, IBD-co-morbidities

16.88

7.33

1.0

—

Mood disorders, excluding more controls

2.98

7.15

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.11

7.14

1.0

—

Implicit Sepsis

3.27

7.10

1.0

—

Poisoning by drugs, medicaments and biological substances

5.59

7.04

1.1

—

Implicit bacterial Sepsis

4.55

6.97

1.0

—

Infections of the skin and subcutaneous tissue

3.13

6.88

1.0

—

Opioids

2.80

6.87

1.1

1.0

—

Nonalcoholic fatty liver disease

8.26

6.81

1.1

—

Transplanted organ and tissue status

10.93

6.79

1.0

—

3.18

6.66

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

5.56

6.66

1.1

—

Substance use, excluding alcohol

6.41

6.62

1.0

—

Zoster [herpes zoster], including avohilmo

3.71

6.57

1.1

1.0

—

Implicit Sepsis, including avohilmo

3.00

6.39

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3.47

6.32

1.0

1.1

—

Ascites

18.04

6.26

1.0

—

Schizophrenia or delusion, excluding more controls

4.00

6.22

1.0

1.1

—

Covid-19 confirmed case

3.95

6.14

1.0

—

Other and unspecified nonorganic psychotic disorders

5.32

6.14

1.0

1.1

—

Autoimmune hepatitis, wide definition

15.05

5.90

1.0

—

Medical observation and evaluation for suspected diseases and conditions

3.36

5.87

1.0

—

Enlarged lymph nodes

11.12

5.79

1.0

—

Mental and behavioural disorders due to alcohol

3.09

5.74

1.0

—

Neurological diseases, wide definition

7.81

5.66

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.80

5.63

1.0

—

Heart failure, not strict

3.05

5.60

1.0

—

Mental and behavioural disorders due to cannabinoids

12.93

5.58

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

10.03

5.53

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.52

5.52

1.0

—

Abnormal findings on examination of blood, without diagnosis

3.54

5.47

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3.46

5.44

1.1

1.0

—

Alcohol use disorder, ICD-based

3.34

5.43

1.0

1.1

—

Implicit viral Sepsis

7.06

5.43

1.0

1.1

—

Viral Sepsis

7.06

5.43

1.0

1.1

—

Other antidepressants

2.63

5.42

1.1

1.0

—

Cirrhosis of liver, NAS

11.29

5.29

1.0

—

Anaemias

6.95

5.28

1.0

—

Type 2 diabetes, wide definition

2.84

5.27

1.0

—

Persons encountering health services for specific procedures and health care

2.38

5.25

1.0

—

L04AD Calcineurin inhibitors

6.68

5.25

1.0

1.1

—

Examination and observation for other reasons

3.27

5.17

1.0

—

Abdominal and pelvic pain

2.63

5.11

1.0

—

Unspecified mental disorder

3.08

5.05

1.0

—

Kela-code for severe mental illness

3.17

5.03

1.0

1.1

—

Poisoning by medicine

4.69

4.98

1.1

—

COPD/asthma related infections

2.47

4.96

1.0

—

COPD/asthma/ILD related infections

2.47

4.96

1.0

—

Anxiety disorders, excluding more controls

2.67

4.94

1.0

—

Acute alcohol intoxication

5.00

4.93

1.0

—

Suicide or other Intentional self-harm

3.66

4.91

1.1

1.0

—

Alcoholic liver disease

11.45

4.78

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.39

4.78

1.0

—

Schizophrenia or delusion

3.27

4.74

1.0

1.1

—

Schizophrenia, schizotypal and delusional disorders

3.27

4.74

1.0

1.1

—

Selective serotonin reuptake inhibitors

2.48

4.65

1.1

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

5.54

4.62

1.0

—

Depression medications

5.03

4.61

1.1

1.0

—

Erysipelas, including avohilmo

2.86

4.58

1.0

1.1

—

Psychiatric diseases

2.55

4.53

1.0

1.1

—

Streptococcal septicaemia, including avohilmo

10.02

4.52

1.0

—

Personality disorders, excluding more controls

4.16

4.49

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

3.01

4.46

1.0

—

Bronchitis

2.25

4.45

1.0

—

Alcohol abuse, main dg, excluding more controls

5.80

4.43

1.0

1.1

—

Any mental disorder

2.39

4.43

1.0

—

Open wound of head

2.78

4.41

1.0

—

Abnormal serum enzyme levels

4.36

4.39

1.0

—

Disorders of adult personality and behaviour

3.09

4.35

1.0

1.1

—

Implicit viral Sepsis, including avohilmo

4.63

4.35

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.77

4.32

1.0

—

Pain, not elsewhere classified

5.00

4.31

1.1

1.0

—

Alcohol dependence

4.49

4.23

1.0

—

Insomnia

2.29

4.18

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

4.80

4.17

1.0

—

Other bacterial intestinal infections

6.93

4.16

1.0

1.1

—

Diabetes, varying definitions

2.24

4.15

1.1

1.0

—

Alcohol abuse, main dg

5.24

4.13

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.25

4.12

1.0

—

Problems related to lifestyle

5.89

4.12

1.0

1.1

—

Diabetes mellitus

2.23

4.11

1.1

1.0

—

Liquid cancers

4.73

4.09

1.0

—

Explicit bacterial Sepsis, including avohilmo

8.01

4.05

1.0

—

Gastrointestinal diseases

2.92

4.05

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.62

4.05

1.1

—

Aplastic and other anaemias

3.37

4.01

1.0

—

Sleep disorders

2.25

3.99

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.90

3.99

1.0

1.1

—

2.19

3.93

1.0

—

Neurotic, stress-related and somatoform disorders

2.22

3.91

1.0

—

Type 2 diabetes

2.23

3.89

1.1

1.0

—

Anxiety disorders

2.21

3.87

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

2.48

3.86

1.0

—

Any event in cancer register

2.27

3.82

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.54

3.80

1.0

—

Codes for special purposes

2.54

3.80

1.0

—

Heart failure,strict

3.10

3.77

1.0

—

Streptococcal septicaemia

8.76

3.77

1.0

—

Convulsions, not elsewhere classified

4.23

3.76

1.1

1.0

—

Other and unspecified anaemias

3.65

3.72

1.0

—

Other anaemias

3.64

3.70

1.0

—

Symptoms and signs involving the urinary system

2.41

3.70

1.0

—

Acute alcohol intoxication, ICD10

4.14

3.69

1.0

—

Cellulitis

4.14

3.69

1.0

—

Personality disorders

3.00

3.68

1.0

—

Concussion

2.63

3.67

1.0

—

Malignant neoplasm, including Hilmo

2.30

3.65

1.0

—

Malignant neoplasm, wide definition

2.29

3.64

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.26

3.61

1.0

—

Any reimbursement code in KELA

2.78

3.59

1.1

1.0

—

Renal tubulo-interstitial diseases

2.29

3.59

1.0

—

Malaise and fatigue

3.03

3.53

1.0

—

Factors influencing health status and contact with health services

5.02

3.51

1.0

—

Complications of surgical and medical care, not elsewhere classified

2.15

3.50

1.0

—

Gonococcal infection

10.04

3.50

1.0

—

Gonococcal infection, including avohilmo

10.03

3.50

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.20

3.48

1.1

1.0

—

Hernia of abdominal wall, postoperative

9.93

3.48

1.0

1.2

—

Malignant neoplasm

2.26

3.42

1.0

—

Malignant neoplasm

2.26

3.42

1.0

—

Heart failure and antihypertensive medication

4.47

3.41

1.0

1.1

—

Assault

4.08

3.39

1.0

—

Emotionally unstable personality disorder

5.01

3.36

1.0

1.1

—

Pleural effusion

7.00

3.36

1.0

—

Explicit bacterial Sepsis

7.00

3.36

1.0

—

Persons encountering health services for specific procedures, not carried out

5.72

3.34

1.0

—

Persons encountering health services for examination and investigation

2.64

3.29

1.1

1.0

—

L04AA Selective immunosuppressants

3.93

3.28

1.0

1.1

—

Implicit fungal Sepsis, including avohilmo

8.58

3.26

1.0

—

Zoster [herpes zoster]

4.74

3.23

1.0

1.1

—

Bacterial intestinal infections, IBD co-morbidities

4.74

3.23

1.0

1.1

—

Acute renal failure

4.74

3.23

1.0

—

Insulin, intermediate and long-acting

2.52

3.21

1.1

1.0

—

Chronic periodontitis, complicated

2.51

3.20

1.1

1.0

—

Diseases of oesophagus, stomach and duodenum

2.01

3.18

1.0

—

Headache

2.49

3.17

1.0

—

Renal failure

2.91

3.16

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

110

2.05

3.14

1.0

—

Disorders of gallbladder, biliary tract and pancreas

2.15

3.14

1.0

—

Special screening examination for infectious and parasitic diseases

3.39

3.13

1.0

—

All-cause Heart Failure

2.71

3.06

1.0

—

Intracranial injury

2.39

3.05

1.0

—

Specific personality disorders

3.17

3.05

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

5.01

3.05

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

5.01

3.05

1.0

—

Ulcer of lower limb, not elsewhere classified

5.00

3.05

1.0

—

All kidney diseases

2.04

3.03

1.0

—

Oxycodone

3.42

3.03

1.1

1.0

—

Erysipelas

2.60

2.99

1.0

1.1

—

Other bacterial intestinal infections, including avohilmo

4.29

2.99

1.0

—

Tramadol

2.27

2.99

1.0

—

Other maltreatment syndromes

10.03

2.98

1.0

—

Heart failure, strict

2.65

2.93

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

4.71

2.91

1.0

—

Metabolic disorders

2.05

2.87

1.0

—

Non-selective monoamine reuptake inhibitors

3.40

2.85

1.0

—

Cutaneous abscess, furuncle and carbuncle

3.16

2.84

1.1

1.0

—

Liquid cancers, including Hilmo

3.21

2.84

1.0

—

Functional dyspepsia

3.57

2.78

1.0

1.1

—

Diabetes medication

1.95

2.78

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.46

2.77

1.0

—

Injuries to the head

103

1.90

2.77

1.0

—

Sleep disorders (combined)

1.94

2.77

1.0

—

Anxiety (asthma-related co-morbidities)

2.27

2.77

1.1

1.0

—

Acute tubulo-interstitial nephritis

2.58

2.76

1.0

—

Hard cardiovascular diseases

2.11

2.76

1.0

—

Excluding asthma or asthma-COPD overlap

2.19

2.75

1.0

—

Other pulmonary diagnosis

2.19

2.75

1.0

—

Unspecified privation

5.01

2.72

1.0

—

Care involving use of rehabilitation procedures

2.31

2.69

1.0

—

Other gastritis (incl. Duodenitis)

4.21

2.67

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.96

2.67

1.1

1.0

—

Solid cancers, including Hilmo

2.08

2.67

1.0

—

Intracranial trauma

2.25

2.66

1.0

—

Type 2 diabetes, definitions combined

2.04

2.65

1.1

1.0

—

COPD differential diagnosis

2.15

2.65

1.0

—

ILD differential diagnosis

2.15

2.65

1.0

—

Candidiasis, including avohilmo

2.79

2.64

1.0

—

Cardiac arrhythmias

2.25

2.62

1.0

—

Transport accidents

2.36

2.62

1.1

1.0

—

Use of hypnotics and sedatives

1.93

2.61

1.0

—

Retention of urine

3.18

2.59

1.0

—

Other heart diseases

2.29

2.59

1.0

—

Pain (limb, back, neck, head abdominally)

2.20

2.59

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

3.60

2.57

1.0

—

Budesonide

4.00

2.56

1.0

1.1

—

Maltreatment syndromes

7.15

2.55

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

2.85

2.54

1.0

—

Other infectious diseases, including avohilmo

5.46

2.54

1.0

—

Benzodiazepine use

103

1.90

2.53

1.0

—

Antihypertensive medication - note that there are other indications

2.09

2.53

1.0

—

Any death

2.43

2.53

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.91

2.53

1.0

—

Major coronary heart disease event

2.08

2.50

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.99

2.49

1.1

1.0

—

Used for control exclusion in common control thyroid runs

1.85

2.49

1.1

1.0

—

Persons encountering health services in other circumstances, wide

1.84

2.48

1.0

—

Atrial fibrillation and flutter with reimbursement

4.20

2.48

1.0

1.1

—

Aortic valve malfunction, age under 60 years

4.38

2.47

1.0

—

Caries of dentine

3.47

2.47

1.0

—

Ischemic heart diseases

2.07

2.47

1.0

—

Insulin medication

2.23

2.46

1.1

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.95

2.46

1.1

1.0

—

Persons with potential health hazards related to communicable diseases

2.30

2.42

1.1

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

3.60

2.40

1.0

1.1

—

Malignant neoplasm of breast, including Hilmo

3.60

2.40

1.0

1.1

—

Finngen Rheumatological endpoints

118

0.38

2.40

1.1

1.0

—

Other sexually transmitted chlamydial diseases

5.01

2.40

1.0

—

Schizophrenia

3.34

2.39

1.0

—

Diseases of male genital organs

2.16

2.38

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

6.26

2.37

1.2

1.0

—

Malignant neoplasm of endocrine gland, including Hilmo

6.26

2.37

1.2

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

6.26

2.37

1.0

—

Acute upper respiratory infections

1.87

2.37

1.0

—

Panic disorder

3.64

2.36

1.1

—

Superficial injury of thorax

4.12

2.36

1.0

1.1

—

Atrial fibrillation and flutter

2.77

2.35

1.0

—

Dental caries

3.04

2.34

1.0

—

Percutaneous Coronary Intervention

2.06

2.34

1.0

—

Coronary revascularization (ANGIO or CABG)

2.06

2.33

1.0

—

Heart failure and coronary heart disease

2.71

2.32

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.87

2.31

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.15

2.31

1.1

1.0

—

Nonorganic sleeping disorders, excluding more controls

3.22

2.30

1.1

—

Cholelithiasis

2.10

2.30

1.1

1.0

—

Gastric ulcer

4.62

2.27

1.0

1.1

—

Complications of medical and surgical care

2.04

2.27

1.1

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.16

2.26

1.1

1.0

—

Fibroblastic disorders

3.11

2.22

1.1

—

Solid cancers

1.98

2.22

1.0

—

Alcohol withdrawal state with delirium

5.56

2.21

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.56

2.21

1.0

1.1

—

Abnormal results of function studies

5.56

2.21

1.0

—

Amiodarone users

5.56

2.21

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

5.56

2.21

1.0

—

Malignant neoplasm of colon

5.56

2.21

1.0

—

Insulin, fast-acting

2.50

2.18

1.2

1.0

—

Exclusions for E4_PCOS_BROAD

3.33

2.17

1.0

—

Exposure to unspecified factor

110

1.79

2.17

1.0

—

Disorders of other endocrine glands

2.24

2.16

1.0

—

Injuries to unspecified part of trunk, limb or body region

4.29

2.15

1.2

1.0

—

L02BG Aromatase inhibitors

3.29

2.15

1.0

—

Emergency coronary revascularization (for ACS)

1.98

2.14

1.0

—

Gastroduodenal ulcer

3.67

2.14

1.0

1.1

—

Malignant neoplasm of colon, including Hilmo

4.27

2.14

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.45

2.13

1.0

1.1

—

Ischaemic heart disease, wide definition

2.09

2.12

1.1

1.0

—

Syncope and collapse

2.62

2.10

1.0

—

Cholelithiasis, broad definition with cholecystitis

2.02

2.08

1.1

1.0

—

Other anxiety disorders

2.16

2.08

1.1

1.0

—

Other infectious diseases

5.01

2.07

1.0

—

Secondary uncertain malignant neoplasm

5.00

2.07

1.0

—

Hypothyroidism, levothyroxine purchases

3.45

2.05

1.3

1.0

—

Hypothyroidism and >3 levothyroxin purchases

3.45

2.05

1.3

1.0

—

Hypothyroidism (congenital or acquired)

3.45

2.05

1.3

1.0

—

Other and unspecified polyneuropathies, also in other diseases

3.50

2.05

1.0

1.1

—

Nephropathy related operations

4.00

2.04

1.0

—

Coronary atherosclerosis

2.19

2.02

1.1

1.0

—

STROKE

2.30

1.99

1.0

—

Malignant neoplasm of breast, HER2-negative

3.22

1.98

1.0

1.1

—

Malignant neoplasm of breast

3.22

1.98

1.0

1.1

—

Cholecystectomy

2.06

1.98

1.1

1.0

—

Artrosis, including avohilmo

0.36

1.98

1.0

—

Valvular heart disease excluding rheumatic fever

2.45

1.96

1.0

—

Malignant neoplasm of digestive organs

2.64

1.94

1.0

—

Acute peritonitis

4.55

1.94

1.0

—

Personal history of malignant neoplasm

4.55

1.94

1.0

1.1

—

Thiazolidinediones

4.55

1.94

1.0

—

Other disorders of urethra and urinary system

2.07

1.93

1.1

1.0

—

Bipolar affective disorders

2.96

1.93

1.0

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.75

1.93

1.0

1.1

—

Nonorganic sleeping disorders

2.73

1.93

1.1

—

Cardiovascular diseases

1.91

1.0

—

Diseases of the skin and subcutaneous tissue

1.78

1.88

1.0

—

Certain disorders involving the immune mechanism

3.18

1.88

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

3.18

1.88

1.0

—

Insulin, fast-acting or short human

2.31

1.87

1.2

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.72

1.86

1.0

—

Other cataract

2.48

1.86

1.0

—

Other disorders of ear

101

0.38

1.82

1.0

—

Diseases of peritoneum

4.17

1.82

1.0

—

Chronic pancreatitis

4.17

1.82

1.0

—

Adjustment and management of implanted device

4.17

1.82

1.0

—

Benign paroxysmal vertigo

2.57

1.80

1.0

1.1

—

Burns and corrosions

3.05

1.80

1.0

—

All anxiety disorders

1.87

1.78

1.1

1.0

—

Statin medication

1.85

1.77

1.0

—

External causes of morbidity and mortality

2.00

1.76

1.1

1.0

—

Chronic periodontitis, including avohilmo

1.73

1.75

1.1

1.0

—

Nausea and vomiting

2.97

1.74

1.0

—

Periodontitis

1.73

1.74

1.1

1.0

—

Malignant neoplasm of breast, HER-positive

3.44

1.72

1.0

1.1

—

Nonsuppurative otitis media

0.00

1.72

0.0

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

3.43

1.72

1.0

1.1

—

Abnormalities of breathing

1.73

1.72

1.0

—

Type 1 diabetes, wide definition, subgroup 1

2.66

1.72

1.0

—

Benign neoplasm of bone and articular cartilage

3.85

1.71

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

3.85

1.71

1.0

—

Other local infections of skin and subcutaneous tissue

3.85

1.71

1.0

—

Palmar fascial fibromatosis [Dupuytren]

3.85

1.71

1.0

—

Other symptoms and signs involving the digestive system and abdomen

3.85

1.71

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.68

1.71

1.0

—

Other disorders of skin and subcutaneous tissue

1.90

1.71

1.0

—

Neurological diseases

1.74

1.71

1.1

1.0

—

1.81

1.69

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.81

1.69

1.0

—

Influenza and pneumonia

108

1.66

1.68

1.0

—

Other diseases of intestines

1.66

1.68

1.0

—

Gingivitis and periodontal diseases

1.72

1.66

1.0

—

Acute and transient psychotic disorders

3.16

1.66

1.0

1.1

—

Colectomy operation

3.16

1.66

1.0

—

Injuries to the ankle and foot

107

1.76

1.66

1.0

—

Autoimmune diseases excluding thyroid diseases

1.64

1.65

1.0

—

Diverticular disease of intestine

1.99

1.63

1.0

—

Disorders of lens

1.98

1.62

1.0

—

Dialysis, with operation codes

3.57

1.61

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.15

1.61

1.0

—

Nonischemic cardiomyopathy

3.57

1.61

1.0

—

Maternal care for other conditions predominantly related to pregnancy

2.73

1.60

1.0

—

Oxicams

0.00

1.58

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

3.00

1.58

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

1.81

1.58

1.0

—

Other heart diseases, wide

1.67

1.57

1.0

—

Other diseases of pleura

2.29

1.55

1.0

—

Oedema, not elsewhere classified

2.93

1.54

1.0

1.1

—

Type 1 diabetes, wide definition

2.42

1.53

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

2.64

1.53

1.0

—

Non-rheumatic valve diseases

2.24

1.53

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3.33

1.52

1.0

—

Abnormal findings on diagnostic imaging of other body structures

3.33

1.52

1.0

1.1

—

Purpura and other haemorrhagic conditions

3.33

1.52

1.0

1.1

—

Abnormal findings on diagnostic imaging of lung

2.17

1.51

1.0

—

Calcific aortic valvular stenosis, operated

2.59

1.50

1.0

—

Calcific aortic valvular stenosis

2.59

1.50

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.59

1.50

1.0

—

Operations 2 for CAVS

2.59

1.50

1.0

—

Superficial injury of ankle and foot

2.86

1.50

1.2

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

2.59

1.50

1.0

—

Nutritional anaemias

2.08

1.49

1.0

—

Other reaction to severe stress, and adjustment disorders

2.07

1.48

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.00

1.48

1.0

—

All chronic kidney diseases

2.03

1.48

1.0

—

ILD medications: immunosuppressive drugs

1.76

1.47

1.0

—

Colorectal cancer, including Hilmo

2.80

1.46

1.0

—

Hyperplasia of prostate

2.41

1.44

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

3.13

1.44

1.0

1.1

—

Osteoporosis

2.76

1.43

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.91

1.42

1.1

1.0

—

Dentofacial anomalies [including malocclusion]

108

0.43

1.42

1.0

—

Other extrapyramidal and movement disorders in other diseases

2.41

1.39

1.1

—

Presence of cardiac and vascular implants and grafts

2.23

1.39

1.0

—

Acute sinusitis

1.82

1.39

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.65

1.37

1.0

—

Follicular cysts of skin and subcutaneous tissue

2.61

1.36

1.0

—

Burns and corrosions of external body surface, specified by site

2.94

1.36

1.0

—

Other metabolic disorders

2.94

1.36

1.0

1.1

—

Lesion of ulnar nerve

2.94

1.36

1.0

1.1

—

Bleeding

1.73

1.35

1.0

—

Arthrosis

0.44

1.35

1.0

—

Glaucoma

2.08

1.34

1.0

—

Other acute lower respiratory infections

1.83

1.34

1.0

—

Superficial injury of wrist and hand

0.00

1.34

0.0

1.1

—

Other (not insulin) diabetes medications

1.65

1.34

1.1

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.14

1.33

1.0

—

Cerebrovascular diseases (FINNGEN)

2.17

1.32

1.0

1.1

—

Bacterial pneumonia, not elsewhere classified

2.14

1.32

1.0

—

Bacterial pneumoniae

2.14

1.32

1.0

—

Complications of procedures, not elsewhere classified

1.70

1.31

1.1

1.0

—

Non-ischemic cardiomyopathy

2.44

1.31

1.0

—

Systemic connective tissue disorders

0.00

1.31

0.0

1.0

—

Other medical care

2.05

1.31

1.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.86

1.30

1.0

—

Superficial injury of head

2.50

1.30

1.0

—

GI-bleeding

2.35

1.29

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.57

1.28

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.78

1.28

1.0

—

Medicines for HER+ breast cancer

2.33

1.28

1.0

1.1

—

Pneumonia, organism unspecified

1.61

1.27

1.0

—

Depression or dysthymia

1.86

1.27

1.1

1.0

—

Other diseases of the digestive system

2.29

1.26

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.56

1.26

1.0

—

Accidents

1.67

1.25

1.0

—

Other external causes of accidental injury

1.67

1.25

1.0

—

Artificial joint operation, meniscal resection

0.48

1.24

1.0

—

Congenital malformations of the circulatory system

2.70

1.24

1.0

1.1

—

Pain in throat and chest

1.60

1.23

1.0

—

Polyp of the female genital tract

0.00

1.21

0.0

1.0

—

Other menopausal disorders

0.00

1.21

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

1.89

1.19

1.1

1.0

—

Chronic apical periodontitis

1.53

1.19

1.0

—

Cough

2.03

1.18

1.0

—

Focal epilepsy

2.31

1.18

1.0

—

Type 1 diabetes

2.10

1.18

1.0

—

Malignant neoplasm of prostate

0.00

1.18

0.0

1.0

—

Malignant neoplasm of prostate, including Hilmo

0.00

1.18

0.0

1.0

—

Disorders of lacrimal system

2.01

1.17

1.1

1.0

—

Dental pulpitis, including avohilmo

104

1.54

1.16

1.0

—

Asthma, unspecified (mode), excluding more controls

1.91

1.16

1.0

—

Gestational [pregnancy-induced] hypertension

0.00

1.16

0.0

1.1

—

Other systemic involvement of connective tissue

0.00

1.16

0.0

1.1

—

Infections with a predominantly sexual mode of transmission

1.93

1.16

1.0

—

Conductive and sensorineural hearing loss

0.43

1.16

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.63

1.15

1.0

—

ILD medications: azathioprine

2.50

1.15

1.0

1.1

—

Acute pancreatitis

2.50

1.15

1.0

—

All influenza (not pneumonia)

2.50

1.15

1.0

1.1

—

Migraine with aura

2.05

1.15

1.0

—

Missing teeth due to accident, extraction or parodontitis

1.81

1.14

1.0

—

Soft tissue disorders

1.53

1.13

1.0

—

Redundant prepuce, phimosis and paraphimosis

2.02

1.13

1.0

1.1

—

Other systemic involvement of connective tissue (FG)

0.00

1.13

0.0

1.1

—

Disorders of skin appendages

1.71

1.13

1.0

—

Endocrine, nutritional and metabolic diseases

1.61

1.11

1.1

1.0

—

Tooth eruption problems

2.41

1.10

1.0

—

Combinations of oral blood glucose lowering drugs

2.26

1.10

1.0

—

Colorectal cancer

2.40

1.09

1.0

—

Azathioprine

2.38

1.09

1.0

—

Myocardial infarction

2.00

1.09

1.0

—

Polyarthropathies

0.48

1.08

1.2

1.0

—

Injuries to the thorax

1.82

1.08

1.0

—

Retinal detachments and breaks

2.19

1.08

1.0

—

Benign neoplasm: Colon

1.88

1.08

1.0

—

Other diseases of urinary system

1.56

1.08

1.0

—

Senile cataract

1.87

1.07

1.0

—

Autoimmune diseases

100

1.47

1.07

1.1

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

1.77

1.06

1.0

—

Periapical abscess

1.76

1.06

1.1

1.0

—

Unspecified haematuria

2.04

1.06

1.0

—

Codeine

1.58

1.06

1.1

1.0

—

Irritable bowel syndrome

2.12

1.05

1.0

1.1

—

All influenza

2.12

1.05

1.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.01

1.05

1.0

—

Diseases of the respiratory system

1.71

1.05

1.1

1.0

—

Unspecified fall

1.75

1.04

1.0

—

Asthma-related pneumonia

1.99

1.04

1.0

—

Asthma-related pneumonia or sepsis

1.99

1.04

1.0

—

Asthma, hospital admissions 3, pneumonia

1.99

1.04

1.0

—

Persons encountering health services in other circumstances

1.84

1.04

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.98

1.04

1.1

1.0

—

Acute pancreatitis (for exclusion)

2.27

1.03

1.0

—

Paralytic ileus and intestinal obstruction

2.27

1.03

1.0

—

D07AA Corticosteroids, weak (group I)

2.27

1.03

1.0

—

Pain in limb

1.57

1.02

1.1

1.0

—

Asthma, unspecified (mode)

1.80

1.01

1.0

—

Iron deficiency anaemia

1.89

1.00

1.0

—

Fracture of shoulder and upper arm

1.87

1.00

1.0

—

Other degenerative diseases of the nervous system

0.00

1.00

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

1.00

0.0

1.0

—

Glaucoma suspect

2.00

1.00

1.0

1.1

—

Constipation

1.57

0.99

1.0

—

Dermatitis and eczema

110

1.45

0.98

1.0

—

Other inflammation of eyelid, including avohilmo

1.71

0.98

1.1

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

101

1.59

0.98

1.1

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

2.17

0.98

1.0

1.1

—

Ventral hernia

2.17

0.98

1.0

—

Focal epilepsy, strict definition

2.17

0.98

1.0

—

Disorders of vestibular function (Vertigo)

1.83

0.97

1.0

—

Fracture of lumbar spine and pelvis

2.17

0.97

1.0

—

Hernia

1.51

0.97

1.0

—

Atopic dermatitis

1.59

0.97

1.1

1.0

—

Biological medication for rheuma

0.00

0.96

0.0

1.1

—

Dermatitis

1.63

0.96

1.0

—

Other hearing loss

0.00

0.95

0.0

1.0

—

Diseases of middle ear and mastoid

0.50

0.95

1.0

—

Recurrent or chronic depression

1.78

0.94

1.1

1.0

—

Umbilical hernia

1.89

0.94

1.0

1.1

—

Asthma/COPD (KELA code 203)

116

0.58

0.93

1.0

—

Other diseases of blood and blood-forming organs, wide

2.14

0.91

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

110

1.45

0.90

1.0

—

Peripheral artery disease

1.97

0.90

1.0

—

Medical abortion

1.72

0.90

1.2

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

0.53

0.90

1.3

1.0

—

Allergic conjunctivitis

0.49

0.89

1.2

1.0

—

Asthma, excluding more controls

1.61

0.88

1.0

—

Benign neoplasms

1.43

0.88

1.0

—

Neoplasms

1.48

0.87

1.0

—

Other spirochaetal diseases, including avohilmo

1.86

0.87

1.3

1.0

—

Other disorders of lacrimal gland

1.86

0.87

1.1

1.0

—

Ganglion

2.00

0.87

1.0

1.1

—

Speech therapy

2.00

0.87

1.0

1.1

—

Intestinal stricture

2.00

0.87

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

109

1.44

0.86

1.0

—

Mycoses, including avohilmo

115

1.46

0.86

1.0

—

Sub-endpoint used in defining T1D endpoints

1.83

0.86

1.0

—

Extrapyramidal and movement disorders

1.82

0.85

1.1

1.0

—

First line medication for Crohn's disease

103

1.41

0.85

1.0

—

Bacterial pneumonia (organism specified)

1.77

0.85

1.0

—

Disturbances of skin sensation

1.78

0.84

1.1

1.0

—

Epilepsy

1.77

0.84

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.78

0.83

1.1

1.0

—

Low back pain

1.49

0.82

1.1

1.0

—

Acne, including avohilmo

1.75

0.82

1.0

—

Enthesopathies of lower limb, excluding foot

1.88

0.81

1.0

—

Other fall from one level to another

1.87

0.81

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

1.61

0.81

1.0

—

Myocardial infarction, strict

1.72

0.80

1.0

—

Pregnancy with abortive outcome

1.65

0.80

1.2

1.0

—

Gastro-oesophageal reflux disease

1.57

0.79

1.0

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.79

0.0

1.1

—

Pedal cyclist injured in transport accident

1.82

0.79

1.0

—

Pre-eclampsia

0.00

0.79

0.0

1.1

—

Dorsopathies

1.41

0.78

1.1

1.0

—

Alzheimer disease, including avohilmo

0.00

0.78

0.0

1.0

—

Pre-eclampsia or eclampsia

0.00

0.78

0.0

1.1

—

All pneumoniae

111

1.40

0.78

1.0

—

Venous thromboembolism

1.72

0.78

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.52

0.78

1.2

1.0

—

Tumor necrosis factor alpha inhibitors

0.00

0.77

0.0

1.1

—

Parasetamol

1.46

0.77

1.1

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.79

0.77

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.77

0.76

1.0

1.1

—

Haemorrhage from respiratory passages

1.77

0.76

1.0

1.1

—

Other and unspecified dermatitis

1.60

0.74

1.0

—

Acute and subacute iridocyclitis

2.08

0.74

1.0

—

Corneal ulcer

2.08

0.74

1.0

—

Disorders of synovium and tendon

1.57

0.74

1.0

—

Acute bronchitis

1.67

0.74

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

1.66

0.74

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.70

0.74

1.0

—

Hypertensive diseases (excluding secondary)

1.57

0.73

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.02

0.73

1.0

—

Embedded and impacted teeth

1.69

0.73

1.0

—

Anterior Iridocyclitis

2.00

0.72

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

2.00

0.72

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

1.42

0.72

1.0

—

Disorders of choroid and retina

1.49

0.72

1.0

—

Diseases of the digestive system

1.59

0.71

1.0

—

Injuries to the shoulder and upper arm

109

1.41

0.71

1.1

1.0

—

In situ neoplasms

1.75

0.71

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.94

0.71

1.0

—

Injury, poisoning and certain other consequences of external causes

1.59

0.70

1.1

1.0

—

Asthma

1.50

0.69

1.0

—

Migraine with aura and triptan purchases

1.85

0.68

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.60

0.68

1.0

—

Coronary artery bypass grafting

1.85

0.68

1.0

—

Acute pharyngitis

1.83

0.68

1.0

—

Diseases of arteries, arterioles and capillaries

1.57

0.67

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.63

0.66

1.0

—

Lyme disease, including avohilmo

1.63

0.66

1.1

1.0

—

Lyme disease

1.63

0.66

1.1

1.0

—

Spirochaetal infections, other/unspecified, including avohilmo

1.63

0.66

1.1

1.0

—

Other spirochaetal diseases

1.63

0.66

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.61

0.66

1.0

—

Fracture of foot, except ankle

1.59

0.65

1.0

—

Episodal and paroxysmal disorders

1.35

0.65

1.1

1.0

—

Hypothyroidism, strict autoimmune

0.58

0.64

1.3

1.0

—

Car occupant injured in other and unspecified transport accidents

1.72

0.64

1.2

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.72

0.64

1.2

1.0

—

Other diseases of anus and rectum

1.72

0.63

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

1.58

0.62

1.0

—

Alzheimer’s disease, strict definition

0.00

0.61

0.0

1.0

—

Injuries to the knee and lower leg

111

1.31

0.61

1.0

—

Conjunctivitis

113

0.64

0.61

1.1

1.0

—

Alzheimer disease

0.00

0.61

0.0

1.0

—

Chronic kidney disease

1.66

0.61

1.0

—

Other hammer toe(s) (acquired)

0.00

0.60

0.0

1.1

—

Adalimumab

0.00

0.60

0.0

1.1

—

Early lumbar disc prolapse operation

0.00

0.60

0.0

1.1

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.60

0.0

1.1

—

All dysplastic lesions of the cervix uteri

1.64

0.60

1.0

1.1

—

Biguanides

1.37

0.60

1.1

1.0

—

Other/unspecified dorsalgia

1.52

0.58

1.1

1.0

—

Other functional intestinal disorders

1.51

0.58

1.0

—

Injury of muscle and tendon at lower leg level

0.00

0.58

0.0

1.0

—

Viral and other specified intestinal infections, including avohilmo

1.51

0.58

1.0

1.1

—

Cystitis

1.44

0.57

1.0

—

Pacemaker

1.69

0.57

1.0

—

Hyperlipidaemia, other/unspecified

1.68

0.57

1.0

—

Suppurative and unspecified otitis media

0.57

0.56

1.0

1.1

—

Irregular menses

1.56

0.56

1.1

1.0

—

Pain in joint

1.50

0.56

1.1

1.0

—

Excessive earwax

0.55

1.0

—

Viral and other specified intestinal infections

1.63

0.55

1.0

—

Soft tissue disorders related to use, overuse and pressure

1.62

0.55

1.0

1.1

—

Hernia of abdominal wall

1.54

0.55

1.0

—

Disorders of conjunctiva

115

0.67

0.54

1.1

1.0

—

Diaphragmatic hernia

1.58

0.54

1.0

1.1

—

Other diseases of lip and oral mucosa

1.50

0.54

1.1

1.0

—

Chronic diseases of tonsils and adenoids

101

0.69

0.54

1.0

—

Meniscus derangement

0.61

0.53

1.0

—

Dental caries, including avohilmo

1.42

0.53

1.1

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.54

0.53

1.0

—

COPD related to multimorbidity

1.54

0.53

1.0

—

Urinary track infection

1.56

0.52

1.0

—

Diseases of inner ear

1.41

0.51

1.0

—

Asthma (mode)

1.41

0.51

1.0

—

Cerebrovascular diseases

1.43

0.50

1.0

—

Lower back pain or/and sciatica

111

1.29

0.48

1.0

—

Obesity

103

0.64

0.48

1.0

—

Obesity and other hyperalimentation

103

0.64

0.48

1.0

—

Complications of labour and delivery

0.60

0.48

1.2

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.45

0.48

1.0

—

Disorders of eyelid, lacrimal system and orbit

1.34

0.47

1.1

1.0

—

Dyspnoea

1.32

0.47

1.0

—

Impacted teeth

1.46

0.47

1.0

—

Gestational diabetes (for exclusion)

1.46

0.47

1.1

1.0

—

Malignant neoplasm of skin

1.44

0.46

1.0

—

Caries of enamel

116

0.73

0.46

1.1

1.0

—

Dermatophytosis, including avohilmo

117

0.67

0.45

1.0

—

Other disorders of veins

1.41

0.45

1.0

—

Other and unspecified effects of external causes

1.40

0.45

1.0

—

Genitourinary diseases

1.37

0.45

1.0

1.1

—

Other diseases of hard tissues of teeth

1.48

0.43

1.1

1.0

—

Diabetic retinopathy, strict definition

1.64

0.43

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.45

0.43

1.1

1.0

—

Iridocyclitis

1.61

0.43

1.0

1.1

—

Fracture of skull and facial bones

1.61

0.43

1.0

—

Migraine without aura

1.61

0.43

1.0

—

Fracture of lower leg, including ankle

1.39

0.43

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.47

0.42

1.0

—

Disorders of breast

1.41

0.42

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.40

0.42

1.0

—

Fall on same level involving ice and snow

1.38

0.42

1.1

1.0

—

Deep bite

0.00

0.41

0.0

1.0

—

Deviated nasal septum

1.38

0.41

1.0

1.1

—

Alzheimer’s disease (Late onset)

0.00

0.41

0.0

1.0

—

Use of donepezil

0.00

0.41

0.0

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.37

0.41

1.0

—

Angina pectoris

1.36

0.41

1.0

—

Exposure to other specified factors

120

1.29

0.41

1.0

—

Atopic dermatitis, strict definition

1.37

0.41

1.0

—

Raynaud syndrome

0.00

0.41

0.0

1.1

—

Seborrhoeic dermatitis

0.00

0.41

0.0

1.1

—

Viral warts

0.00

0.41

0.0

1.1

—

Early lumbar disc prolapse, operated

0.00

0.41

0.0

1.1

—

Postpartum haemorrhage due to anatomy

0.00

0.41

0.0

1.1

—

Coeliac disease

0.00

0.41

0.0

1.1

—

Lung diseases due to external agents

0.00

0.41

0.0

1.0

—

Sleep apnoea, including avohilmo

105

0.75

0.41

1.1

1.0

—

Ankylosing spondylitis, ICD10

0.00

0.41

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.41

0.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

105

1.27

0.41

1.1

1.0

—

Multiple delivery

0.00

0.40

0.0

1.0

—

Other psoriatic arthropathies

0.00

0.40

0.0

1.1

—

Open wound of forearm

0.00

0.40

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

0.40

0.0

1.1

—

Psoriatic arthropathies

0.00

0.40

0.0

1.1

—

Methotrexate

0.00

0.40

0.0

1.1

—

Inflammatory disease of uterus

0.00

0.40

0.0

1.1

—

Basal cell carcinoma

1.48

0.40

1.0

—

Sequelae of cerebrovascular disease

1.47

0.40

1.0

—

Use of other anti-dementia drugs

0.00

0.40

0.0

1.0

—

Use of memantine

0.00

0.40

0.0

1.0

—

Otitis externa, unspecified

0.00

0.40

0.0

1.1

—

Dermatophytosis

0.00

0.40

0.0

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.36

0.39

1.0

—

Arthropathic psoriasis

0.00

0.39

0.0

1.1

—

Psoriatic and enteropathic arthropathies

0.00

0.39

0.0

1.1

—

Recurrent aphthous stomatitis , including avohilmo

0.00

0.39

0.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.35

0.38

1.0

—

Other and unspecified iron deficiency

1.39

0.38

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

101

1.31

0.37

1.0

—

Falls/tendency to fall

1.24

0.37

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

116

0.78

0.36

1.0

—

Persons encountering health services in circumstances related to reproduction

0.73

0.36

1.1

1.0

—

Procreative management

0.63

0.36

1.0

—

Polycystic ovarian syndrome, consortium definition

1.35

0.35

1.1

1.0

—

Dorsalgia

1.24

0.34

1.1

1.0

—

Other disorders of eyelid

1.35

0.34

1.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

107

1.28

0.34

1.0

—

COPD, hospital admissions

1.33

0.33

1.0

—

Other chronic obstructive pulmonary disease

1.33

0.33

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

105

1.22

0.33

1.0

—

Diabetes mellitus in pregnancy

1.31

0.33

1.2

1.0

—

Diseases of the ear and mastoid process

117

0.81

0.33

1.0

—

Pure hypercholesterolaemia

1.31

0.33

1.0

—

Asthma, hospital admission 2, infections

1.31

0.33

1.0

—

Asthma-related infections

1.31

0.33

1.0

—

Open wound of wrist and hand

0.67

0.33

1.0

—

ILD medications

107

1.21

0.33

1.0

—

COPD, early/later onset

1.29

0.32

1.0

—

COPD

1.28

0.32

1.0

—

Fall on same level

106

1.21

0.32

1.0

—

Migraine

1.31

0.32

1.0

—

DVT of lower extremities and pulmonary embolism

1.27

0.32

1.0

—

Diabetic retinopathy, excluding more controls

1.35

0.32

1.0

—

Malignant neoplasm of skin, including Hilmo

1.30

0.30

1.0

—

Organic, including symptomatic, mental disorders

1.30

0.30

1.0

—

Nerve, nerve root and plexus disorders

104

1.21

0.30

1.0

—

Asthma (diagnoses ohter than nonallergic)

111

1.24

0.30

1.0

—

Other dorsopathies, not elsewhere classified

1.21

0.29

1.1

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.31

0.29

1.0

—

Inflammatory bowel disease

1.25

0.29

1.0

—

Triptan medication for migraine, min. 3 purchases

0.73

0.29

1.0

—

Asthma (only as main-diagnosis), excluding more controls

1.30

0.29

1.0

—

Stroke, excluding SAH

1.31

0.28

1.0

—

Injuries to the hip and thigh

1.30

0.28

1.1

1.0

—

Noninfective enteritis and colitis

1.31

0.27

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.78

0.27

1.2

1.0

—

Necrosis of pulp, including avohilmo

102

1.26

0.27

1.1

1.0

—

Caries of dentine, including avohilmo

1.26

0.26

1.1

1.0

—

Other and unspecified tonsillitis

0.70

0.26

1.4

1.0

—

Diseases of the eye and adnexa

1.20

0.26

1.1

1.0

—

Hypertensive diseases

1.21

0.25

1.0

—

Hypertension

1.21

0.25

1.0

—

Stroke, including SAH

1.20

0.25

1.0

—

Sciatica+with lumbago

1.19

0.24

1.1

1.0

—

Inflammatory diseases of female pelvic organs

0.72

0.24

1.0

—

Osteopathies and chondropathies

1.17

0.24

1.0

—

Injuries to the wrist and hand

120

0.83

0.24

1.1

1.0

—

Codeine or tramadol medication

107

1.17

0.24

1.1

1.0

—

Arthropathies

0.83

0.24

1.1

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.31

0.23

1.2

1.0

—

Hypothyroidism, other/unspecified

0.80

0.23

1.2

1.0

—

Basal cell carcinoma, including Hilmo

1.30

0.23

1.0

—

Dysplasia of cervi uteri

1.30

0.23

1.0

—

Cardiodefibrillation

1.28

0.22

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.25

0.22

1.0

1.1

—

Myocardial infarction, without ST-elevation

1.22

0.22

1.0

—

IBD patients in KELA-register

1.22

0.22

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.22

0.22

1.2

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.22

0.22

1.2

1.0

—

Symptoms and signs involving speech and voice

1.22

0.22

1.0

—

Other enthesopathies

1.22

0.22

1.0

—

Lumbar disc prolapse

1.23

0.21

1.1

1.0

—

Specific development disorders of speech and language

0.00

0.21

0.0

1.0

—

Unspecified/other endometriosis

0.00

0.21

0.0

1.1

—

Crowding of teeth, including avohilmo

0.00

0.21

0.0

1.0

—

Inflammatory bowel disease, strict (require KELA)

1.19

0.21

1.0

—

Astigmatism

0.00

0.21

0.0

1.0

—

Hypermetropia

0.00

0.21

0.0

1.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

1.1

—

Non-allergic asthma

0.00

0.21

0.0

1.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.21

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

0.21

0.0

1.0

—

Convergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Osteonecrosis

0.00

0.21

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.21

0.0

1.0

—

Benign neoplasm: Choroid

0.00

0.21

0.0

1.0

—

Etanercept

0.00

0.21

0.0

1.0

—

Drug-induced neutropenia

0.00

0.21

0.0

1.0

—

Paralytic strabismus

0.00

0.21

0.0

1.0

—

Other necrotizing vasculopathies

0.00

0.21

0.0

1.0

—

Viral pneumonia (unknown virus, not influenza)

0.00

0.21

0.0

1.0

—

Crohn's disease of small intestine

0.00

0.21

0.0

1.0

—

Vasomotor rhinitis (mode)

0.00

0.21

0.0

1.0

—

Sequelae of infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

Sequelae of infectious and parasitic diseases, including avohilmo

0.00

0.21

0.0

1.0

—

Carcinoma in situ of skin

0.00

0.21

0.0

1.0

—

Heterophoria

0.00

0.21

0.0

1.1

—

Sicca syndrome [Sjögren]

0.00

0.21

0.0

1.1

—

Nummular dermatitis

0.00

0.21

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.21

0.0

1.1

—

Ménière disease

0.00

0.21

0.0

1.1

—

Other specified/unspecified hearing loss

0.00

0.21

0.0

1.0

—

Other ill-defined and unspecified causes of mortality

0.00

0.21

0.0

1.0

—

Scoliosis

0.00

0.21

0.0

1.1

—

Ill-defined and unknown causes of mortality

0.00

0.21

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

0.21

0.0

1.1

—

Retinal detachment with retinal break

0.00

0.21

0.0

1.0

—

Other embolism and thrombosis

0.00

0.21

0.0

1.1

—

Viral pneumonia

0.00

0.21

0.0

1.0

—

Dental operations

1.26

0.21

1.1

1.0

—

Other osteochondropathies

0.00

0.21

0.0

1.0

—

Viral infections of the central nervous system

0.00

0.21

0.0

1.0

—

Viral infections of the central nervous system, including avohilmo

0.00

0.21

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

0.21

0.0

1.0

—

Allergic urticaria

0.00

0.21

0.0

1.0

—

Ocular pain

0.00

0.21

0.0

1.1

—

Other peripheral vertigo

0.00

0.21

0.0

1.1

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.21

0.0

1.1

—

Cervicocranial syndrome

0.00

0.21

0.0

1.1

—

Impacted cerumen

0.00

0.21

0.0

1.0

—

Other/unspecified rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.0

—

Polymyalgia rheumatica

0.00

0.21

0.0

1.0

—

Other disorders of breast

0.00

0.21

0.0

1.2

—

Congenital malformations of genital organs

0.00

0.21

0.0

1.2

—

Dementia in Alzheimer disease

0.00

0.21

0.0

1.0

—

Effects of foreign body entering through natural orifice

1.16

0.21

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.1

—

Pyogenic arthritis

0.00

0.21

0.0

1.0

—

Presbyopia

0.00

0.21

0.0

1.1

—

Other congenital malformations of skin, including avohilmo

0.00

0.21

0.0

1.1

—

Demyelinating diseases of the central nervous system

0.00

0.21

0.0

1.1

—

Benign neoplasm of meninges

0.00

0.21

0.0

1.1

—

Cervical polyps

0.00

0.21

0.0

1.1

—

Primary hyperparathyroidism

0.00

0.21

0.0

1.1

—

Bronchitis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

ILD, hospital admissions 1, main diag only

0.00

0.21

0.0

1.0

—

ILD, hospital admissions

0.00

0.21

0.0

1.0

—

Other interstitial pulmonary diseases

0.00

0.21

0.0

1.0

—

Interstitial lung disease endpoints

0.00

0.21

0.0

1.0

—

Interstitial lung disease

0.00

0.21

0.0

1.0

—

Other congenital malformations

0.00

0.21

0.0

1.1

—

Type1 diabetes, definitions combined, early onset

0.00

0.21

0.0

1.0

—

Personal history of other diseases and conditions

0.00

0.20

0.0

1.2

—

Presbycusis

0.00

0.20

0.0

1.0

—

Spondylopathies

0.79

0.20

1.1

1.0

—

Other contact dermatitis

0.00

0.20

0.0

1.1

—

Twin gestation

0.00

0.20

0.0

1.1

—

Multiple gestation

0.00

0.20

0.0

1.1

—

Other benign neoplasms of connective and other soft tissue

0.00

0.20

0.0

1.0

—

Seronegative rheumatoid arthritis

0.00

0.20

0.0

1.1

—

Familial hypercholesterolemia

0.00

0.20

0.0

1.0

—

Atrophic disorders of skin

0.00

0.20

0.0

1.1

—

Other respiratory diseases principally affecting the interstitium

0.00

0.20

0.0

1.0

—

Hyperparathyroidism

0.00

0.20

0.0

1.1

—

Other nutritional deficiencies

104

0.79

0.20

1.0

—

Asthma (only as main-diagnosis)

1.22

0.19

1.0

—

Disorders of vitreous body and globe

1.20

0.18

1.0

—

Papulosquamous disorders

1.21

0.18

1.0

—

Injuries to the elbow and forearm

104

0.82

0.18

1.0

—

Mouth breathing

1.18

0.18

1.0

—

Diabetic retinopathy

1.14

0.17

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.17

0.17

1.0

—

Other intervertebral disc disorders

1.18

0.17

1.1

1.0

—

Disease of hard tissues of teeth, NOS

1.20

0.17

1.0

—

Keratitis

1.13

0.17

1.0

—

Dizziness and giddiness

1.20

0.17

1.1

1.0

—

Tonsillectomy and adenotomy

0.83

0.17

1.0

—

Disorders of the thyroid gland

0.85

0.17

1.2

1.0

—

Excessive attrition of teeth

100

1.19

0.16

1.0

—

Chronic sinusitis

1.13

0.16

1.0

—

Other retinal disorders

1.14

0.15

1.0

—

Sleep apnoea

102

0.86

0.15

1.1

1.0

—

L04AX Other immunosuppressants

1.20

0.15

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

101

1.16

0.14

1.0

—

Inguinal hernia

0.79

0.14

1.0

1.1

—

Acute appendicitis, no complications

0.84

0.13

1.1

1.0

—

Shoulder lesions

0.82

0.13

1.0

—

Asthma, hospital admissions , main diagnosis only

119

0.88

0.11

1.0

—

Chronic lower respiratory diseases

116

0.91

0.11

1.0

—

Autoimmune diseases related-to ILD

122

0.89

0.10

1.0

—

Oral corticosteroids

110

0.91

0.10

1.0

—

Conjunctivitis (acute, non atopic)

1.13

0.10

1.0

—

Other and unspecified disorders of vitreous body

1.11

0.09

1.0

—

Cervical disc disorders

1.11

0.09

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

1.06

0.09

1.0

—

Melanocytic naevi

1.04

0.09

1.0

—

Other viral diseases

1.09

0.08

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.90

0.08

1.0

—

Triptan medication for migraine, single purchase ok

0.90

0.08

1.0

—

Acetic acid derivatives and related substances

1.13

0.08

1.0

—

Disorders of vitreous body

1.04

0.08

1.0

—

Ischaemic Stroke, excluding all haemorrhages

0.82

0.08

1.0

—

Contact with and exposure to communicable diseases

0.83

0.08

1.0

—

Coxarthrosis, primary

0.77

0.08

1.0

—

Propionic acid derivatives

1.04

0.08

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

1.04

0.08

1.0

—

Other headache syndromes

1.07

0.08

1.1

1.0

—

Striking against or struck by other objects

1.06

0.08

1.0

1.1

—

Second line medication for Crohn's disease

1.13

0.08

1.0

—

Leiomyoma of uterus

0.82

0.08

1.2

1.0

—

Visual disturbances

0.86

0.07

1.0

—

Temporomandibular joint disorders, including avohilmo

0.83

0.07

1.0

—

1.04

0.07

1.0

—

Carpal tunnel syndrome

0.87

0.07

1.1

1.0

—

Reimbursement for rheumatic diseases

0.84

0.07

1.1

1.0

—

Fracture of forearm

1.02

0.07

1.0

—

Asthma, including avohilmo

117

0.94

0.05

1.0

—

Acute appendicitis

111

0.92

0.04

1.1

1.0

—

Other arrhythmias

1.10

0.04

1.0

—

Other diseases of upper respiratory tract

104

1.05

0.03

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.07

0.02

1.0

—

Appendectomy

107

1.07

0.02

1.1

1.0

—

Inflammatory bowel disease treatment related agents

115

0.96

0.01

1.0

—

Diseases of appendix

113

0.95

0.01

1.1

1.0

—

Appendicitis, broad definition

113

0.95

0.00

1.1

1.0

—

Other neurological diseases

1.06

0.00

1.0

—

Other specific joint derangements/joint disorders

0.98

0.00

1.1

1.0

—

Hypertension, essential

1.00

0.00

1.0

—

Other joint disorders

1.02

0.00

1.1

1.0

—

Pneumothorax

0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.0

1.1

—

Abnormal blood-pressure reading, without diagnosis

0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

0.0

1.1

—

Arthropathies in other diseases classified elsewhere

0.00

0.0

1.0

—

Osteoporosis with pathological fracture (FG)

0.00

0.0

1.0

—

Emphysema

0.00

0.0

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.0

1.0

—

Other disorders of male genital organs

0.00

0.0

1.0

—

Crohn's disease NAS

0.00

0.0

1.0

—

Non-small cell lung cancer

0.00

0.0

1.0

—

Rubella [German measles]

0.00

0.0

1.0

—

Other juvenile arthritis

0.00

0.0

1.0

—

Nontoxic single thyroid nodule

0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.2

—

Glaucoma, exfoliation

0.00

0.0

1.0

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.0

—

Fracture at wrist and hand level

0.87

0.00

1.0

—

Fracture of neck

0.00

0.0

1.0

—

Disorder of external ear, unspecified

0.00

0.0

1.0

—

Exposure to smoke, fire and flames

0.00

0.0

1.0

—

Dermatographic urticaria

0.00

0.0

1.1

—

Benign neoplasm of male genital organs

0.00

0.0

1.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.0

1.0

—

Other peripheral vascular diseases

0.00

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.0

1.0

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.0

1.0

—

Neuralgia and neuritis, unspecified

0.00

0.0

1.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Viral meningitis

0.00

0.0

1.0

—

Mental retardation

0.00

0.0

1.0

—

Benign neoplasm: Skin of trunk

0.00

0.0

1.0

—

Lichen simplex chronicus and prurigo

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

-0.00

0.0

1.0

—

Pustulosis palmaris et plantaris

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.1

—

Excessive, frequent and irregular menstruation

0.92

-0.00

1.2

1.0

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

1.0

—

Other specified/unspecified systemic involvement of connective tissue

0.00

-0.00

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

L02BX Other hormone antagonists and related agents

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.0

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Melanoma in situ

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Squamous cell neoplasms and carcinomas of the skin

0.00

-0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.0

—

Rotator cuff syndrome

0.98

-0.00

1.0

1.1

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.02

-0.00

1.0

—

Spasmodic torticollis

0.00

-0.00

0.0

1.0

—

Effects of other external causes

0.00

-0.00

0.0

1.0

—

Idiopathic gout

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.0

—

Psoriasis (vulgaris), strict definition

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.0

—

Open wound of hip and thigh

0.00

-0.00

0.0

1.0

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.0

—

Glaucoma-related operations

0.00

-0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

-0.00

0.0

1.2

—

Endometriosis

1.00

-0.00

1.2

1.0

—

Alzheimer disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Tongue abnormality

0.00

-0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.2

—

Tuberculosis

0.00

-0.00

0.0

1.0

—

Contact with sharp glass

0.00

-0.00

0.0

1.0

—

Viral meningitis, including avohilmo

0.00

-0.00

0.0

1.0

—

Femoral hernia

0.00

-0.00

0.0

1.0

—

Asthma and opportunity respiratory infection

0.00

-0.00

0.0

1.0

—

Other diseases of arteries and capillaries

0.00

-0.00

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

1.0

—

Convalescence

0.00

-0.00

0.0

1.0

—

Contraceptive management

0.92

-0.00

1.3

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

1.0

—

Artificial opening status

0.00

-0.00

0.0

1.0

—

Respiratory tuberculosis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

0.00

-0.00

0.0

1.0

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

1.0

—

Follicular lymphoma, hilmo

0.00

-0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.0

—

Mental retardation, wide definition

0.00

-0.00

0.0

1.0

—

Manic episode

0.00

-0.00

0.0

1.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Other specified disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

1.0

—

Postmenopausal osteoporosis with pathological fracture

0.00

-0.00

0.0

1.0

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

1.0

—

Respiratory tuberculosis, confirmed and not-confirmed

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.2

—

Extreme obesity with alveolar hypoventilation

0.00

-0.00

0.0

1.0

—

Hemiplegia

0.00

-0.00

0.0

1.0

—

Other neurotic disorders

0.00

-0.00

0.0

1.0

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

1.0

—

Other specified/unspecified dorsopathies

0.00

-0.00

0.0

1.0

—

Other viral diseases, including avohilmo

0.89

-0.00

1.0

—

Other specified disorders of external ear

0.00

-0.00

0.0

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.98

-0.00

1.0

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.0

—

Disorders of acoustic nerve

0.00

-0.00

0.0

1.0

—

Cholesteatoma of middle ear

0.00

-0.00

0.0

1.0

—

Otosclerosis

0.00

-0.00

0.0

1.0

—

Other/unspecified disorders of vestibular function

0.00

-0.00

0.0

1.0

—

Spermatocele

0.00

-0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.2

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

1.0

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

-0.00

0.0

1.2

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Hypertrophic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.2

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.0

—

Mandibular retrognathia

0.00

-0.00

0.0

1.0

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.0

—

conjunctival haemorrhage

0.00

-0.00

0.0

1.0

—

Visual disturbances and blindness

0.92

-0.00

1.0

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

1.2

—

Dystonia

0.00

-0.00

0.0

1.0

—

Atopic conjunctivitis

0.00

-0.00

0.0

1.0

—

Noise effects on inner ear

0.00

-0.00

0.0

1.0

—

Pyothorax

0.00

-0.00

0.0

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

1.00

-0.00

1.0

—

Acute gastritis

0.00

-0.00

0.0

1.0

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

1.0

—

Cerebral cysts

0.00

-0.00

0.0

1.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.0

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.0

—

False labour

1.00

-0.00

1.2

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

-0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.0

—

Other erythematous conditions

0.00

-0.00

0.0

1.0

—

Other arthrosis

0.91

-0.00

1.0

1.1

—

Non-small cell lung cancer, adenocarcinoma

0.00

-0.00

0.0

1.0

—

L02BB Anti-androgens

0.00

-0.00

0.0

1.0

—

Wide developmental disorders

0.00

-0.00

0.0

1.0

—

Agoraphobia

0.00

-0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.0

—

Osteomyelitis

0.00

-0.00

0.0

1.0

—

Polyarthritis, unspecified

0.00

-0.00

0.0

1.0

—

Pustular psoriasis

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases

0.00

-0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.0

—

Hypermobility syndrome

0.00

-0.00

0.0

1.0

—

Bicipital tendinitis

0.00

-0.00

0.0

1.0

—

Spondylosis

1.01

-0.00

1.1

1.0

—

Golimumab

0.00

-0.00

0.0

1.0

—

Lesion of sciatic nerve

0.00

-0.00

0.0

1.0

—

Degenerative macular diseases

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.0

—

Cyst of kidney

0.00

-0.00

0.0

1.0

—

Giant cell arteritis

0.00

-0.00

0.0

1.0

—

Calculus of lower urinary tract

0.00

-0.00

0.0

1.0

—

Deep endometriosis

0.00

-0.00

0.0

1.1

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

-0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Torsion of testis

0.00

-0.00

0.0

1.0

—

Chronic iridocyclitis

0.00

-0.00

0.0

1.0

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Transient ischemic attack

1.02

-0.00

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

1.0

—

Other necrotizing vasculopathies (FG)

0.00

-0.00

0.0

1.0

—

Pleural plaque with presence of asbestos

0.00

-0.00

0.0

1.0

—

Puerperal sepsis

0.00

-0.00

0.0

1.1

—

Juvenile arthritis (FINNGEN)

0.00

-0.00

0.0

1.0

—

Failed induction of labour

0.00

-0.00

0.0

1.1

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Use of rasagiline

0.00

-0.00

0.0

1.0

—

Lichen simplex chronicus

0.00

-0.00

0.0

1.0

—

Hypertrophic scar

0.00

-0.00

0.0

1.0

—

Erosion of teeth , including avohilmo

1.00

-0.00

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hepatitis D virus Ab [Presence] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS